Development of cyclosporine-induced linear IgA bullous dermatosis despite concurrent use of dapsone

Karissa Libson; Kristin L Koenig; Catherine G Chung; Abraham M Korman

doi:10.1016/j.jdcr.2023.08.008

Development of cyclosporine-induced linear IgA bullous dermatosis despite concurrent use of dapsone

JAAD Case Rep. 2023 Aug 19:40:74-76. doi: 10.1016/j.jdcr.2023.08.008. eCollection 2023 Oct.

Authors

Karissa Libson¹, Kristin L Koenig², Catherine G Chung³, Abraham M Korman⁴

Affiliations

¹ Ohio State University College of Medicine, Columbus, Ohio.
² Department of Hematology, Ohio State University Wexner Medical Center, Columbus, Ohio.
³ Department of Pathology, Ohio State University Wexner Medical Center, Columbus, Ohio.
⁴ Department of Dermatology, Ohio State University Wexner Medical Center, Columbus, Ohio.

No abstract available

Keywords: bullous disease; cutaneous signs of disease; drug reaction; immunology and immunologic disorders; inflammatory skin disease; linear IgA bullous dermatosis; therapy and treatment.

Publication types

Case Reports